Spotlight
Cancer Type
About CURE
Sign Up for eNews
Role of Tivozanib in Renal Cell Carcinoma (RCC) : Episode 3
Tivozanib: Adverse Event Profile and How Toxicities are Managed
Dr Thomas Hutson reviews the adverse event profile of tivozanib and provides advice to community oncologists on how to best manage these toxicities.
EP: 1.Treatment Options for Patients with Renal Cell Carcinoma (RCC)
EP: 2.Clinical Implications of the TIVO-3 Trial
Now Viewing
EP: 3.Tivozanib: Adverse Event Profile and How Toxicities are Managed
EP: 4.Experience with Tivozanib in the 3rd Line Setting for Patients with RCC
EP: 5.Future Perspectives in Renal Cell Carcinoma (RCC)
Related Videos
Related Content
